Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation: Results at 24 Months

NCT00377962 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.

NCT NCT00377962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00377962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation: Results at 24 Months
Lead sponsor
Novartis Pharmaceuticals
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2005
Completion date
February 28, 2010
Enrollment
282 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

disorder related to cardiac transplantation